Maximillian Merz

31PUBLICATIONS

177CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Molecular targetsHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Jun 12, 2026

Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Mar 31, 2026

Pharmacokinetics of CAR T cells in multiple myeloma - the good, the bad, and the ugly.

Maximilian Merz, Eric Jurgens, David Fandrei

|Mar 31, 2026

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT.

Nico Gagelmann, Maximilian Merz, Laurien G A Baaij

|Feb 17, 2026

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

Thomas C Wiemers, Nora Grieb, Maximilian Ferle

|Dec 10, 2025

Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy.

Lukas Scheller, Xiang Zhou, Henry Loeffler-Wirth

Pageof 6

Frequent Collaborators

12 joint publications

Vladan Vučinić

Uwe Platzbecker

Kristin Reiche

Nico Gagelmann

Madlen Jentzsch

Klaus Metzeler

Georg-Nikolaus Franke

4 joint publications

Sebastian Schwind

4 joint publications

David Fandrei

4 joint publications

Song-Yau Wang

Frequent Collaborators

12 joint publications

Vladan Vučinić

9 joint publications

Uwe Platzbecker

7 joint publications

Kristin Reiche

6 joint publications

Nico Gagelmann